Literature DB >> 12460457

Identification of the CAB2/hCOS16 gene required for the repair of DNA double-strand breaks on a core amplified region of the 17q12 locus in breast and gastric cancers.

Masahiko Nezu1, Michiko Nishigaki, Tomoki Ishizuka, Yoshitaka Kuwahara, Chikako Tanabe, Kazuhiko Aoyagi, Hiromi Sakamoto, Yasushi Saito, Teruhiko Yoshida, Hiroki Sasaki, Masaaki Terada.   

Abstract

We previously reported that CAB1 and c-ERBB-2 genes were found to be located in a core amplified region of the 17q12 locus, which is frequently amplified in various cancers. During identification of this core region, CAB2, a human homologue of the yeast COS16 required for the repair of DNA double-strand breaks was cloned. Autofluorescence analysis of cells transfected with its GFP fusion protein demonstrated that CAB2 translocates into vesicles, suggesting that overexpression of CAB2 may decrease intercellular Mn2+ by accumulating it in the vesicles, in the same way as yeast COS16. This is the first report identifying all of the genes on the core amplified region of the 17q12 locus in breast and gastric cancers.

Entities:  

Mesh:

Year:  2002        PMID: 12460457      PMCID: PMC5926894          DOI: 10.1111/j.1349-7006.2002.tb01221.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  24 in total

1.  DNA polymerase delta isolated from Schizosaccharomyces pombe contains five subunits.

Authors:  S Zuo; E Gibbs; Z Kelman; T S Wang; M O'Donnell; S A MacNeill; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Isolation of a candidate gene, CAB1, for cholesterol transport to mitochondria from the c-ERBB-2 amplicon by a modified cDNA selection method.

Authors:  N Akiyama; H Sasaki; T Ishizuka; T Kishi; H Sakamoto; M Onda; H Hirai; Y Yazaki; T Sugimura; M Terada
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

3.  Cdc1 and the vacuole coordinately regulate Mn2+ homeostasis in the yeast Saccharomyces cerevisiae.

Authors:  M Paidhungat; S Garrett
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

4.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

5.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

6.  Mutations in the Saccharomyces cerevisiae CDC1 gene affect double-strand-break-induced intrachromosomal recombination.

Authors:  J Halbrook; M F Hoekstra
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.

Authors:  G Reifenberger; J Reifenberger; K Ichimura; P S Meltzer; V P Collins
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

8.  Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.

Authors:  J A Squire; P S Thorner; S Weitzman; J D Maggi; P Dirks; J Doyle; M Hale; R Godbout
Journal:  Oncogene       Date:  1995-04-06       Impact factor: 9.867

Review 9.  Gene amplification and tumor progression.

Authors:  O Brison
Journal:  Biochim Biophys Acta       Date:  1993-05-25

10.  The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer.

Authors:  D Stein; J Wu; S A Fuqua; C Roonprapunt; V Yajnik; P D'Eustachio; J J Moskow; A M Buchberg; C K Osborne; B Margolis
Journal:  EMBO J       Date:  1994-03-15       Impact factor: 11.598

View more
  1 in total

1.  HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.

Authors:  P R Benusiglio; P D Pharoah; P L Smith; F Lesueur; D Conroy; R N Luben; G Dew; C Jordan; A Dunning; D F Easton; B A J Ponder
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.